The role of specialization in our economy dates back to the 18th century. Now fast-forward to healthcare in the present day: one application of specialization is the concept of a focused factory, where care providers focus on one or two specific organs or disease processes. Host Dr. Jack Lewin welcomes Dr. Regina Herzlinger, the Nancy R. McPherson Professor of Business Administration at Harvard Business School, for an interesting conversation about the potential role of focused factories in healthcare. We have seen this model take hold in a few areas of medicine, including cardiology, but is the time ripe for an expansion of the focused factory model? Dr. Herzlinger also explains where a specialty hospital or a general tertiary care facility would fit within this system.
Focused Factories: A Path to Reduce Cost and Boost Quality

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
The role of specialization in our economy dates back to the 18th century. Now fast-forward to healthcare in the present day: one application of specialization is the concept of a focused factory, where care providers focus on one or two specific organs or disease processes. Host Dr. Jack Lewin welcomes Dr. Regina Herzlinger, the Nancy R. McPherson Professor of Business Administration at Harvard Business School, for an interesting conversation about the potential role of focused factories in healthcare. We have seen this model take hold in a few areas of medicine, including cardiology, but is the time ripe for an expansion of the focused factory model? Dr. Herzlinger also explains where a specialty hospital or a general tertiary care facility would fit within this system.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Personalizing Care Within the RCC Treatment Paradigm
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
NYHA FC and Finerenone Response: Clinical Trial Insights
Semaglutide improves walking distance, symptoms and QoL in patients with PAD and T2D
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?